Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 423 (OTC: $CSUI) (CSE: $IPOT.C) (OTC: $OWPC)(TSX: $VLNS.TO) (CSE: $HOLL.C)
Delta, Kelowna, BC, June 4, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company's facilities for producing cannabis are based in Zurich.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.
In today’s podcast we will be looking at a few public company announcements.
Isracann Biosciences Inc. (CSE: IPOT) (OTC: ISCNF) announced their support of the recent government approval permitting the export of cannabis for sale to foreign medicinal markets.
On May 13, 2020, the Israeli Ministry of Economy signed a Free Export Order for medical cannabis products. The order allows the government to implement a medical cannabis decision that was previously signed in 2019. The order was announced to go into effect 30 days from the signing, at which time licensed producers of medical cannabis in Israel will be able to apply for an export permit to ship product to international markets. Accordingly, Isracann has tasked its regional consultants with ensuring applications for an export permit will be made as soon as possible.
As reported by Israel’s Globes Business News, the Ministry of Health stated it will permit exports while ensuring adequate supplies for medical cannabis in the Israeli market. During the second half of 2019, after the Health Ministry's new medical cannabis reform came into effect, the tightened medical cannabis manufacturing and processing standards proved complex for many producers, while at the same time making it easier for patients to obtain licensed access creating a gap in supply. The media outlet further reported that the Ministry of Economy has announced that revenue from medical cannabis exports is expected to reach hundreds of millions of dollars each year. In the sector, it is estimated that if the country leverages early approval for exports, a more significant place could be taken in the global market.
Isracann CEO Darryl Jones notes, “As we have noted previously, supply in both the domestic and European markets is lagging behind demand, especially in Europe as more countries work on less restrictive regulations. Our timely ability to jump into the gap will be a great opportunity for Isracann. Additionally, our marketing strategy aims to leverage Israeli-branded products as fundamentally superior due to the unique environment and advanced agronomics Israel offers. We look forward to working with our consultants and the Ministry to ensure we are ready to apply for export permitting as soon as the application process is clarified.”
The Company also announced today that Mr. Matt Chatterton has been promoted from his role as VP, Operations to the position of Chief Operating Officer. His proven background in manufacturing including project and facility management, logistics, supply side processes and procedures has been utilized extensively since joining the Company. Mr. Chatterton has fully engaged with every aspect of the operation within Israel. His intimate knowledge and relationships across the organizational structure and understanding of the Company’s goals will continue to prove invaluable as commercialization advances.
“I am very grateful for this vote of confidence and the latitude it provides,” Mr. Chatterton comments. “As we move ahead into commercialization, I am confident that our team can quickly advance towards revenue generation and sustainable growth.”
The Company wishes to acknowledge and thank Mr. Israel Moseson who steps down from his role as COO. As a founding member of Isracann, he was instrumental in the early stage growth of the business. We sincerely wish him well in his future endeavors.
One World Pharma Inc. (OTC: OWPC) announced that effective immediately, NBA legend, international entrepreneur and philanthropist Isiah Thomas has been appointed as its CEO and Vice-Chairman of the Board of Directors. Mr. Thomas will replace founder and CEO Craig Ellins who is retiring.
Isiah Thomas, while forever known for his Hall of Fame career as a 12-time NBA All Star, two-time NBA champion, and inclusion as one of the 50 Greatest Players in NBA History, is an accomplished and highly regarded international business executive and investor with a portfolio of companies he has developed via Isiah International Inc. Mr. Thomas has previously served on the Chicago Stock Exchange’s Board of Governors, was a co-founder of the NBA’s Toronto Raptors, Popcorn Indiana, and is a member of the Board of Get-in Chicago, an organization focused on preventing gang violence in Chicago, since 2013.
His business interests include sports and entertainment, real estate, waste management, his cannabis and CBD products company, VESL Oils, and more. Notably, Mr. Thomas has developed a highly successful champagne business with Cheurlin Champagnes, where he has cultivated an excellent relationship with both the grower, employees and the French government. Mr. Thomas now uniquely owns genetics for the grapes produced for the champagne and has perfected an international import/export system for international distribution of the product.
Mr. Thomas inherits the reins of an ascendant international hemp and cannabis company which under Mr. Ellins’ leadership has seen significant development and progress, including the establishment of highly scalable farm and production facilities in Colombia, a portfolio of fully registered elite and government approved genetic strains, and a state sanctioned THC quota.
The Board of Directors is grateful to Mr. Ellins and thanks him for his innovation, dedication, and determination.
“We are elated to welcome Isiah Thomas to the One World Pharma leadership team and to have him continue and expand upon the successes of Craig Ellins,” stated Dr. Kenneth Perego, Executive Chairman of One World Pharma. “Mr. Thomas is the ideal person to lead us in this new phase as we commence commercial sales and revenues, lending to our cause his international business experience, myriad relationships, and commitment to winning.”
“It is truly an honor to work with Mr. Thomas on the One World Pharma opportunity and to leverage his experience in such similar verticals to the benefit of the Company, its shareholders and our indigenous partners in Colombia,” added Brian Moore, President, One World Pharma.
“I am honored to join One World Pharma and its excellent team. It is a company that is leading the way in innovation in the hemp and cannabis industry,” said Isiah Thomas, CEO and Vice-Chairman. “The company’s deep commitment to excellence in their products and for its customers positions us well to continue to grow as an international leader in the industry. Its recognition for its humanitarian efforts validates its mission as a socially conscious company in a true partnership with the indigenous people.”
The Valens Company (TSX: VLNS) (OTCQX: VLNCF) announced a custom manufacturing agreement with TREC Brands Inc., a cannabis brand house with a mission of doing good.
Under the agreement between The Valens Company and TREC Brands, The Valens Company will manufacture vape pens across three existing TREC brands; Thumbs Up Brand, WINK, and Blissed, with the potential to later produce other innovative products. TREC has already launched a successful line of tinctures, flower, and pre-rolls, but through this partnership, vape pens will be introduced as a new product format across its current brand portfolio. The TREC Agreement follows a royalty-based payment structure.
TREC's mission is to build socially conscious, purposeful brands with commitments to initiatives that positively impact Canadian communities, the planet, and society as a whole. Each brand in their portfolio has a distinct mission that reflects the core values of the brand house:
● WINK curates unique products and partners with local designers to collaborate on accessories. The brand donates 10% of profits to advance local communities with a focus on progressing culture in fashion, art and music.
● Blissed strives to empower women to shed stigma and live happier, healthier and more authentic existences through educational content, community building and purposefully designed products.
● Thumbs Up Brand aims to deliver high quality cannabis at a fair price to the grower and the consumer.
The execution of the TREC Agreement further solidifies the strength in The Valens Company's customized manufacturing platform that both Licensed Producers and CPG partners utilize to launch products and further their brands in the evolving Canadian market. The Company remains focused on its further development into a leading manufacturer of cannabinoid-based products and continues to broaden its customer product platform from its existing offering of capsules, tinctures, sprays, vapes, beverages, concentrates, distillate, isolate, and SōRSE by Valens emulsion, and expects to also include topicals and edibles in the near to medium term. With this platform, The Valens Company leads the industry as a one-stop-shop and manufacturer of high quality oil-based product formats.
"Through this partnership, The Valens Company and TREC will thoughtfully bring to market high-quality, bespoke products while putting the unique needs of Canadian consumers at the forefront of product development," said Tyler Robson, CEO of The Valens Company. "As Cannabis 2.0 continues to allow for exciting new products and brands to hit shelves in Canada, we are excited to develop products in partnership with authentic, community-centric brands such as those in the TREC portfolio."
"With The Valens Company's capabilities and expertise to provide customized products to suit each of our brands, we are confident that we are delivering the best possible products to our consumers with a company who values community-level engagement as much as we do," said Trang Trinh, Founding Director and CEO of TREC Brands.
Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) announced that the Company's 100% owned subsidiary, AlphaMind Brands Inc. plans to launch medicinal mushroom based capsule and powder product lines.
The initial product line will consist of a blended and bottled powder and capsule consisting of powdered cordyceps, lion's mane, oyster, reishi and shiitake medicinal mushroom varietals. The formulations for both products are unique and developed through research driven initiatives. The health benefits that the capsules and powder intend to provide include but are not limited to anti-inflammatory, antioxidant, anti-aging, anti-microbial and immune system support.
Raw materials for the product line have arrived at Alphamind's manufacturing partner, Kirkman and have been sent off for third party testing. Once the ingredients are approved, AlphaMind anticipates production can begin by mid-June with the aim of having the product line in the market by mid-July 2020.
Dr. Nikos Apostolopoulos, CSO of AlphaMind shared, "Our AlphaMind five mushroom blend will be a game changer for both athletes and non-athletes alike. This ethically sourced and organically grown blend provides potent antioxidants, and anti-inflammatory responses, helping to improve and maximize performance as well as daily activities."
Once again, today’s podcast was sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company's facilities for producing cannabis are based in Zurich.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an
ucts or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: CSUI is a paid news and social media sock on investor ideas. More disclaimer info:
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Contact Investorideas.com
800 665 0411
